Get notified of page updates
Search Results: Treatment + Colorectal Cancer (1 results)
New Search
PRINTER FRIENDLY PAGE
1 through 1 of
1
Treatment
Phase 1/2 treatment study for advanced colorectal, pancreatic or lung cancer with a KRAS G12C mutation
Treating Advanced Solid Tumors with a KRAS G12C Mutation Using Targeted Therapies Called RAS(ON) Inhibitors
This study is testing two new investigational targeted drugs called RAS(ON) inhibitors alone or in combination with each other to learn how safe they are and how well they may work in people with advanced or metastatic solid tumors that have a biomarker called a KRAS G12C mutation.
Clinicaltrials.gov identifier:
NCT06128551
Additional Results on Clinicaltrials.gov Treatment + Colorectal Cancer + KRAS G12C
2 results
| Clinical Trial | Official Title |
|---|---|
| NCT05786924 | Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies |
| NCT06720987 | A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies |
Sponsored By
